Company Overview of Suneva Medical, Inc.
Suneva Medical, Inc., an aesthetics company, develops, manufactures, and commercializes products for the general dermatology and aesthetic markets. It offers Bellafill, a dermal filler for the correction of nasolabial folds and atrophic, and distensible facial acne scars on the cheek of patients; ReFissa, a tretinoin for reduction of fine lines, wrinkles, hyperpigmentation, and tactile roughness; Regenica, a solution to stimulate skin’s natural repair and renewal mechanisms; and Vibrance Rejuvenation System that provides solutions for enhancing skin’s appearance and reduces the signs of aging. It serves clients in the United States, Canada, Korea, and Singapore. The company has a strategic p...
5870 Pacific Center Boulevard
San Diego, CA 92121
Founded in 2008
Key Executives for Suneva Medical, Inc.
Chairman of the Board and Chief Executive Officer
Vice President of Corporate Development
Compensation as of Fiscal Year 2015.
Suneva Medical, Inc. Key Developments
Suneva Medical Announces Clinical Study Confirming Long-Term Safety of Bellafill through Five Years
Sep 10 15
Suneva Medical, Inc. announced that Bellafill® is now the only Health Canada approved dermal filler with demonstrated safety through five years, following the completion of its five year post-approval study for nasolabial folds. The study marks the large and longest prospective dermal filler study ever conducted, with unprecedented retention, high patient satisfaction and strong evidence to support the long-term safety of Bellafill®. Patients who have experienced dermal filler fatigue or are frustrated with the recurring costs associated with filler treatments and time spent at appointments may consider Bellafill® for natural-looking and long-lasting correction. The five year post-approval study on the use of Bellafill® in the nasolabial folds was primarily designed to determine its long-term safety, whereas, subject satisfaction was a secondary objective. There were 1,008 patients enrolled across 23 study centers. At five years, an impressive 87% retention rate was observed with the majority of patients (83%) rating a 'satisfied' to 'very satisfied' outcome with their Bellafill® treatment at the conclusion of the five year study. No treatment-related serious adverse events (SAEs) or unanticipated adverse events were noted. The incidence of treatment-related adverse events (TRAEs) in patients was 11.7%. The majority of these events were mild in severity and resolved by the conclusion of the study. The most commonly reported TRAEs were lumpiness at the injection site and redness (1.8%). The incidence of granulomas was infrequent (1.7%). Bellafill® is the only dermal filler approved by Health Canada for the correction of nasolabial folds that is proven safe though five years. A total of 1,542 patients have been treated with Bellafill® across four clinical studies.1 Three of the four studies were conducted on 1,399 patients treated with Bellafill® in support of the indication for the correction of nasolabial folds. One of the four studies was conducted on 143 patients treated with Bellafill® for the correction of moderate to severe, atrophic, distensible facial acne scars on the cheek. Suneva Medical's recent announcement that it has raised $35.4 million in financing for ongoing product commercialization efforts and expansion of business development activities provides a strong basis for the continued growth of Bellafill®.
Suneva Medical, Inc. Introduces Regenica Revitalizing Eye Crme
Jun 11 15
Suneva Medical, Inc. announced that it has introduced Regenica Revitalizing Eye Crme, the first and only eye crme developed with the combination of MRC next generation growth factor technology, advanced peptides, powerful antioxidants and moisturizing agents. Regenica Revitalizing Eye Crme is specifically formulated for the delicate skin around the eye and is clinically proven to decrease the appearance of lines and wrinkles in the crow's feet and under eye areas. The crme is the latest addition to the Regenica skin care line, a family of next generation anti-aging products that help prevent and reverse signs of aging.
Suneva Medical Introduces Regenica® Recovery Gel
Mar 23 15
Suneva Medical, Inc. announced the introduction and availability of Regenica® Recovery Gel, a new addition to the Regenica® skin care system. Regenica® Recovery Gel is a soothing balm that is specially formulated to help quickly heal damaged skin. It infuses Multipotent Resignaling Complex (MRCx™) next generation growth factor technology with well-recognized and trusted natural anti-inflammatory and calming agents, arnica, vitamin K, aloe vera, beta-glucan and SymCalmin®, to help in the overall appearance of compromised skin. Regenica® Recovery Gel is part of the popular Regenica® product line that includes Regenica® Renew SPF 15, Regenica® Replenishing Crème and Regenica® Repair Complex.
Similar Private Companies By Industry
Recent Private Companies Transactions
July 28, 2015